|Chennai||Rs. 27580.00 (0.18%)|
|Mumbai||Rs. 28700.00 (0%)|
|Delhi||Rs. 27700.00 (0.73%)|
|Kolkata||Rs. 28270.00 (0%)|
|Kerala||Rs. 27050.00 (0.74%)|
|Bangalore||Rs. 27350.00 (1.11%)|
|Hyderabad||Rs. 27660.00 (1.21%)|
: Johnson & Johnson's fourth-quarter net income jumped, mainly because of big charges a year ago. It made $2.57 billion, or 91 cents per share, on revenue of $17.56 billion. It expects 2013 earnings per share of $5.35 to $5.45.
ONGOING TROUBLES: Some consumer health products included in J&J's 30-plus recalls since 2009 still won't be back in stores this year, and consumer sales dipped again.
POSSIBLE SALE: J&J is mulling the sale or spinoff of its Ortho Clinical Diagnostics business, which makes equipment and supplies for detecting and diagnosing diseases.